Black Diamond Therapeutics, Inc.
2020 Q2 - 2026 Q2 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q2 | 7/29/2026 | 56 | 0.0% | 30,300 | 6/30/2026 |
| 2025 Q1 | 10/8/2025 | 7 | 0.0% | 4,400 | 3/31/2025 |
| 2024 Q4 | 10/8/2025 | 9 | 0.0% | 4,400 | 12/31/2024 |
| 2024 Q3 | 10/8/2025 | 19 | 0.0% | 4,400 | 9/30/2024 |
| 2024 Q2 | 10/8/2025 | 99 | 0.0% | 21,300 | 6/30/2024 |
| 2022 Q2 | 8/4/2022 | 0 | 0.0% | 194 | 6/30/2022 |
| 2022 Q1 | 7/1/2022 | 30 | 0.0% | 10,694 | 3/31/2022 |
| 2021 Q4 | 2/2/2022 | 57 | 0.0% | 10,694 | 12/31/2021 |
| 2021 Q3 | 11/2/2021 | 141 | 0.0% | 16,722 | 9/30/2021 |
| 2021 Q2 | 8/2/2021 | 203 | 0.0% | 16,648 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 400 | 0.0% | 16,500 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 529 | 0.0% | 16,500 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 402 | 0.0% | 13,300 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 460 | 0.0% | 10,900 | 6/30/2020 |